BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Oct. 19, 2004
View Archived Issues
Ranbaxy scientists describe new iminosugar-based anticancer agents
Read More
Novel polo-like kinase inhibitors developed at GSK
Read More
New GLP-1 analogues and their use covered by SCRAS patent
Read More
Theravance researchers claim dual beta2-AR agonists/muscarinic antagonists
Read More
Novel 5-HT6 receptor ligands in early development at Wyeth
Read More
New p38 MAP kinase inhibitors identified by GSK researchers
Read More
New peptide with vasodilatory activity isolated from frog skin secretion
Read More
Chiesi scientists prepare and test new gamma-secretase inhibitors for AD
Read More
R&D highlights from the 4th Annual Biotech In Europe Investor Forum: CareX
Read More
R&D highlights from the 4th Annual Biotech In Europe Investor Forum: Chroma Therapeutics
Read More
R&D highlights from the 4th Annual Biotech In Europe Investor Forum: DeveloGen
Read More
Positive in vivo report comparing MDI-P to tobramycin
Read More
Positive phase III results for Neupro in advanced Parkinson's
Read More
UCB Pharma in Parkinson's collaboration with Brigham and Women's Hospital
Read More
UCB Pharma to discontinue Olux, Luxiq copromotion
Read More
Remicade receives European approval for psoriatic arthritis
Read More
Approvable letter for Riquent
Read More
Niaspan approved in France
Read More
Luveris approved for concomitant use with Gonal-f
Read More
Potential clinical effects reported for the HIV-1 integrase inhibitor L-870810
Read More
CoFactor designated orphan drug in Europe for pancreatic cancer
Read More
Symadex enters second phase I study
Read More
Benefits of a good adherence to bisphosphonates in patients with osteoporosis
Read More
New data on the therapeutic effects of raloxifene in osteoporosis
Read More
Topiramate as a novel approach to alcoholism
Read More
Conclusion of dose-escalating phase I study for DB-289
Read More
RPI-78M successfully completes studies in MS animal model
Read More
Encouraging interim results from phase I study of ACP-HIP
Read More
Viventia Biotech seeks orphan drug status for Proxinium
Read More
InNexus to develop S(T15) SuperAntibody for coronary heart disease
Read More
Proposed merger of Aventis into sanofi-aventis
Read More
Activation of PARP and erectile dysfunction
Read More